ArticleCommunications chemistry2022
Characterization of the cholangiocarcinoma drug pemigatinib against FGFR gatekeeper mutants.
Qianmeng Lin et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
15 papers cite it
this papertrialcites it